Expands LATAM Footprint First Supply Agreement Costa Rica
Filed with ASX · · 4 pages · English
Summary by 6ix AI
Bioxyne Limited has announced its first supply agreement for medicinal cannabis flower to Costa Rica, marking an expansion into the LATAM market. The agreement with Remidose LATAM includes the supply of three cannabis flower stock keeping units and represents the first international supply in Costa Rica's regulated market. Initial shipments are expected to exceed a specified value and will support the introduction of the Dr Watson® brand in the region. This expansion builds on a previous agreement and highlights strong demand and strategic alignment between Bioxyne and Remidose.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Story so far
Earlier from Bioxyne
- Manufacturing Agreement Aurora Supplementary Information
- Bioxyne Signs Manufacturing Agreement with Aurora Cannabis
- BXN H1 FY2026 Results Presentation
- Stronger H1 FY2026 Performance Upward Revision to Guidance
- Half Yearly Report and Accounts
Later from Bioxyne
All Bioxyne news releasesFollow Bioxyne into a list and get an email when it puts out news.
Follow Bioxyne